Status:
WITHDRAWN
A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts
Lead Sponsor:
Centre Leon Berard
Conditions:
Haematological Malignancy
Acute Leukemia
Eligibility:
All Genders
8-21 years
Phase:
NA
Brief Summary
To date, allogeneic haematopoietic stem cell transplantation (aHSCT) is the only curative treatment for many paediatric and young adult haematological pathologies (acute leukaemia, myelodysplastic syn...
Eligibility Criteria
Inclusion
- 8 years ≤ Age ≤ 21 years
- Size more or equal to 110 cm.
- Histologically or cytologically confirmed malignant or non-malignant haemopathy
- Indication for hematopoietic stem cell allograft.
- Hospitalization in a protected room at IHOP/DAJAC.
- Certificate of no contraindication to the practice of an APA, issued by the oncologist or attending physician.
- Having available in the sterile room a smartphone (iPhone 5S version for Apple/version 5 under Android at least) or a tablet (for the realization of the connected challenges) during the whole hospitalization period.
- Written consent signed and dated by the patient or the parents of minor patients with the acceptance of the minor.
Exclusion
- Severe Heart Disease and Uncontrolled Cardiovascular Disease
Key Trial Info
Start Date :
December 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04331483
Start Date
December 8 2018
End Date
September 1 2023
Last Update
February 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut d'Hématologie et d'Oncologie Pédiatrique
Lyon, France, 69008